Cargando…

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease activity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dam, Koos P.J., Wieske, Luuk, Stalman, Eileen W., Kummer, Laura Y.L., Roosen, Jesse, van Kempen, Zoé L.E., Killestein, Joep, Volkers, Adriaan G., Boekel, Laura, Wolbink, Gerrit J., van der Kooi, Anneke J., Raaphorst, Joost, Löwenberg, Mark, Takkenberg, R. Bart, D'Haens, Geert R.A.M., Spuls, Phyllis I., Bekkenk, Marcel W., Musters, Annelie H., Post, Nicoline F., Bosma, Angela L., Hilhorst, Marc L., Vegting, Yosta, Bemelman, Frederike J., Voskuyl, Alexandre E., Broens, Bo, Sanchez, Agner Parra, van Els, Cécile A.C.M., de Wit, Jelle, Rutgers, Abraham, de Leeuw, Karina, Horváth, Barbara, Verschuuren, Jan J.G.M., Ruiter, Annabel M., van Ouwerkerk, Lotte, van der Woude, Diane, Allaart, Renée C.F., Teng, Y.K. Onno, van Paassen, Pieter, Busch, Matthias H., Jallah, Papay B.P., Brusse, Esther, van Doorn, Pieter A., Baars, Adája E., Hijnen, Dirk Jan, Schreurs, Corine R.G., van der Pol, W.Ludo, Goedee, H. Stephan, Steenhuis, Maurice, Keijzer, Sofie, Keijser, Jim B.D., Cristianawati, Olvi, Rispens, Theo, Brinke, Anja ten, Verstegen, Niels J.M., Marieke van Ham, S., Tas, Sander W., Kuijpers, Taco W., Eftimov, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805902/
https://www.ncbi.nlm.nih.gov/pubmed/36621174
http://dx.doi.org/10.1016/j.jaut.2022.102984
_version_ 1784862422356459520
author van Dam, Koos P.J.
Wieske, Luuk
Stalman, Eileen W.
Kummer, Laura Y.L.
Roosen, Jesse
van Kempen, Zoé L.E.
Killestein, Joep
Volkers, Adriaan G.
Boekel, Laura
Wolbink, Gerrit J.
van der Kooi, Anneke J.
Raaphorst, Joost
Löwenberg, Mark
Takkenberg, R. Bart
D'Haens, Geert R.A.M.
Spuls, Phyllis I.
Bekkenk, Marcel W.
Musters, Annelie H.
Post, Nicoline F.
Bosma, Angela L.
Hilhorst, Marc L.
Vegting, Yosta
Bemelman, Frederike J.
Voskuyl, Alexandre E.
Broens, Bo
Sanchez, Agner Parra
van Els, Cécile A.C.M.
de Wit, Jelle
Rutgers, Abraham
de Leeuw, Karina
Horváth, Barbara
Verschuuren, Jan J.G.M.
Ruiter, Annabel M.
van Ouwerkerk, Lotte
van der Woude, Diane
Allaart, Renée C.F.
Teng, Y.K. Onno
van Paassen, Pieter
Busch, Matthias H.
Jallah, Papay B.P.
Brusse, Esther
van Doorn, Pieter A.
Baars, Adája E.
Hijnen, Dirk Jan
Schreurs, Corine R.G.
van der Pol, W.Ludo
Goedee, H. Stephan
Steenhuis, Maurice
Keijzer, Sofie
Keijser, Jim B.D.
Cristianawati, Olvi
Rispens, Theo
Brinke, Anja ten
Verstegen, Niels J.M.
Marieke van Ham, S.
Tas, Sander W.
Kuijpers, Taco W.
Eftimov, Filip
author_facet van Dam, Koos P.J.
Wieske, Luuk
Stalman, Eileen W.
Kummer, Laura Y.L.
Roosen, Jesse
van Kempen, Zoé L.E.
Killestein, Joep
Volkers, Adriaan G.
Boekel, Laura
Wolbink, Gerrit J.
van der Kooi, Anneke J.
Raaphorst, Joost
Löwenberg, Mark
Takkenberg, R. Bart
D'Haens, Geert R.A.M.
Spuls, Phyllis I.
Bekkenk, Marcel W.
Musters, Annelie H.
Post, Nicoline F.
Bosma, Angela L.
Hilhorst, Marc L.
Vegting, Yosta
Bemelman, Frederike J.
Voskuyl, Alexandre E.
Broens, Bo
Sanchez, Agner Parra
van Els, Cécile A.C.M.
de Wit, Jelle
Rutgers, Abraham
de Leeuw, Karina
Horváth, Barbara
Verschuuren, Jan J.G.M.
Ruiter, Annabel M.
van Ouwerkerk, Lotte
van der Woude, Diane
Allaart, Renée C.F.
Teng, Y.K. Onno
van Paassen, Pieter
Busch, Matthias H.
Jallah, Papay B.P.
Brusse, Esther
van Doorn, Pieter A.
Baars, Adája E.
Hijnen, Dirk Jan
Schreurs, Corine R.G.
van der Pol, W.Ludo
Goedee, H. Stephan
Steenhuis, Maurice
Keijzer, Sofie
Keijser, Jim B.D.
Cristianawati, Olvi
Rispens, Theo
Brinke, Anja ten
Verstegen, Niels J.M.
Marieke van Ham, S.
Tas, Sander W.
Kuijpers, Taco W.
Eftimov, Filip
author_sort van Dam, Koos P.J.
collection PubMed
description For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease activity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this substudy of a prospective observational cohort study (Target-to-B!), we included patients with IMIDs who received a SARS-CoV-2 vaccine. Patients reported changes in disease activity on a five-point Likert scale every 60 days for up to twelve months after first vaccination. In case of self-reported increased activity, hospital records were screened whether the treating physician reported increased activity, and for potential intensification of immunosuppressive (ISP) treatment. Mixed models were used to study determinants for self-reported increased disease activity. In total, 2111 patients were included for analysis after primary immunization (mean age 49.7 years [SD 13.7], 1329/2111 (63.0%) female), from which 1266 patients for analysis after first additional vaccination. Increased disease activity at 60 days after start of primary immunization was reported by 223/2111 (10.6%). In 96/223 (43.0%) the increase was confirmed by the treating physician and in 36/223 (16.1%) ISP treatment was intensified. Increased disease activity at seven to 60 days after additional vaccination, was reported by 139/1266 (11.0%). Vaccinations were not temporally associated with self-reported increased disease activity. Conversely, increased disease activity before first vaccination, neuromuscular disease, and multiple sclerosis were associated. Altogether, self-reported increased disease activity after vaccination against SARS-CoV-2 was recorded in a minority of patients and was generally mild. Moreover, multivariate analyses suggest that disease related factors, but not vaccinations are the major determinants for self-reported increased disease activity.
format Online
Article
Text
id pubmed-9805902
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-98059022023-01-04 Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations van Dam, Koos P.J. Wieske, Luuk Stalman, Eileen W. Kummer, Laura Y.L. Roosen, Jesse van Kempen, Zoé L.E. Killestein, Joep Volkers, Adriaan G. Boekel, Laura Wolbink, Gerrit J. van der Kooi, Anneke J. Raaphorst, Joost Löwenberg, Mark Takkenberg, R. Bart D'Haens, Geert R.A.M. Spuls, Phyllis I. Bekkenk, Marcel W. Musters, Annelie H. Post, Nicoline F. Bosma, Angela L. Hilhorst, Marc L. Vegting, Yosta Bemelman, Frederike J. Voskuyl, Alexandre E. Broens, Bo Sanchez, Agner Parra van Els, Cécile A.C.M. de Wit, Jelle Rutgers, Abraham de Leeuw, Karina Horváth, Barbara Verschuuren, Jan J.G.M. Ruiter, Annabel M. van Ouwerkerk, Lotte van der Woude, Diane Allaart, Renée C.F. Teng, Y.K. Onno van Paassen, Pieter Busch, Matthias H. Jallah, Papay B.P. Brusse, Esther van Doorn, Pieter A. Baars, Adája E. Hijnen, Dirk Jan Schreurs, Corine R.G. van der Pol, W.Ludo Goedee, H. Stephan Steenhuis, Maurice Keijzer, Sofie Keijser, Jim B.D. Cristianawati, Olvi Rispens, Theo Brinke, Anja ten Verstegen, Niels J.M. Marieke van Ham, S. Tas, Sander W. Kuijpers, Taco W. Eftimov, Filip J Autoimmun Article For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease activity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this substudy of a prospective observational cohort study (Target-to-B!), we included patients with IMIDs who received a SARS-CoV-2 vaccine. Patients reported changes in disease activity on a five-point Likert scale every 60 days for up to twelve months after first vaccination. In case of self-reported increased activity, hospital records were screened whether the treating physician reported increased activity, and for potential intensification of immunosuppressive (ISP) treatment. Mixed models were used to study determinants for self-reported increased disease activity. In total, 2111 patients were included for analysis after primary immunization (mean age 49.7 years [SD 13.7], 1329/2111 (63.0%) female), from which 1266 patients for analysis after first additional vaccination. Increased disease activity at 60 days after start of primary immunization was reported by 223/2111 (10.6%). In 96/223 (43.0%) the increase was confirmed by the treating physician and in 36/223 (16.1%) ISP treatment was intensified. Increased disease activity at seven to 60 days after additional vaccination, was reported by 139/1266 (11.0%). Vaccinations were not temporally associated with self-reported increased disease activity. Conversely, increased disease activity before first vaccination, neuromuscular disease, and multiple sclerosis were associated. Altogether, self-reported increased disease activity after vaccination against SARS-CoV-2 was recorded in a minority of patients and was generally mild. Moreover, multivariate analyses suggest that disease related factors, but not vaccinations are the major determinants for self-reported increased disease activity. Published by Elsevier Ltd. 2023-02 2023-01-02 /pmc/articles/PMC9805902/ /pubmed/36621174 http://dx.doi.org/10.1016/j.jaut.2022.102984 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
van Dam, Koos P.J.
Wieske, Luuk
Stalman, Eileen W.
Kummer, Laura Y.L.
Roosen, Jesse
van Kempen, Zoé L.E.
Killestein, Joep
Volkers, Adriaan G.
Boekel, Laura
Wolbink, Gerrit J.
van der Kooi, Anneke J.
Raaphorst, Joost
Löwenberg, Mark
Takkenberg, R. Bart
D'Haens, Geert R.A.M.
Spuls, Phyllis I.
Bekkenk, Marcel W.
Musters, Annelie H.
Post, Nicoline F.
Bosma, Angela L.
Hilhorst, Marc L.
Vegting, Yosta
Bemelman, Frederike J.
Voskuyl, Alexandre E.
Broens, Bo
Sanchez, Agner Parra
van Els, Cécile A.C.M.
de Wit, Jelle
Rutgers, Abraham
de Leeuw, Karina
Horváth, Barbara
Verschuuren, Jan J.G.M.
Ruiter, Annabel M.
van Ouwerkerk, Lotte
van der Woude, Diane
Allaart, Renée C.F.
Teng, Y.K. Onno
van Paassen, Pieter
Busch, Matthias H.
Jallah, Papay B.P.
Brusse, Esther
van Doorn, Pieter A.
Baars, Adája E.
Hijnen, Dirk Jan
Schreurs, Corine R.G.
van der Pol, W.Ludo
Goedee, H. Stephan
Steenhuis, Maurice
Keijzer, Sofie
Keijser, Jim B.D.
Cristianawati, Olvi
Rispens, Theo
Brinke, Anja ten
Verstegen, Niels J.M.
Marieke van Ham, S.
Tas, Sander W.
Kuijpers, Taco W.
Eftimov, Filip
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
title Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
title_full Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
title_fullStr Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
title_full_unstemmed Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
title_short Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
title_sort disease activity in patients with immune-mediated inflammatory diseases after sars-cov-2 vaccinations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805902/
https://www.ncbi.nlm.nih.gov/pubmed/36621174
http://dx.doi.org/10.1016/j.jaut.2022.102984
work_keys_str_mv AT vandamkoospj diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT wieskeluuk diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT stalmaneileenw diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT kummerlaurayl diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT roosenjesse diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vankempenzoele diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT killesteinjoep diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT volkersadriaang diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT boekellaura diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT wolbinkgerritj diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vanderkooiannekej diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT raaphorstjoost diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT lowenbergmark diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT takkenbergrbart diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT dhaensgeertram diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT spulsphyllisi diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT bekkenkmarcelw diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT mustersannelieh diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT postnicolinef diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT bosmaangelal diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT hilhorstmarcl diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vegtingyosta diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT bemelmanfrederikej diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT voskuylalexandree diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT broensbo diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT sanchezagnerparra diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vanelscecileacm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT dewitjelle diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT rutgersabraham diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT deleeuwkarina diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT horvathbarbara diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT verschuurenjanjgm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT ruiterannabelm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vanouwerkerklotte diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vanderwoudediane diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT allaartreneecf diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT tengykonno diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vanpaassenpieter diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT buschmatthiash diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT jallahpapaybp diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT brusseesther diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vandoornpietera diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT baarsadajae diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT hijnendirkjan diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT schreurscorinerg diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT vanderpolwludo diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT goedeehstephan diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT steenhuismaurice diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT keijzersofie diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT keijserjimbd diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT cristianawatiolvi diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT rispenstheo diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT brinkeanjaten diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT verstegennielsjm diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT mariekevanhams diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT tassanderw diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT kuijperstacow diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT eftimovfilip diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations
AT diseaseactivityinpatientswithimmunemediatedinflammatorydiseasesaftersarscov2vaccinations